TechValidate Research on QIAGEN Digital Insights

These pages present data that TechValidate has sourced via direct research with verified customers and users of QIAGEN Digital Insights. TechValidate stands behind the authenticity of all published data. Learn more »



3,522 Customers Surveyed

24,323 Data Points Collected

316 Published TechFacts

29 Published Charts

23 Published Case Studies



Featured Research Collections for QIAGEN Digital Insights

Curated collections and slideshows of TechValidate research data on QIAGEN Digital Insights.



Selected Research Highlights


QIAGEN Bioinformatics Customer Satisfaction Rating

10 out of 10 stars for CLC Genomics Workbench

Dr. Joachim Schnabl at University of Zurich would be very likely to recommend CLC Genomics Workbench:

CLC workbench is great!

QIAGEN Bioinformatics Customer Satisfaction Rating

A Professor at a small business computer software company would be very likely to recommend QIAGEN Bioinformatics for this reason:

Excellent software at a good price point.

Top purchasing drivers for Ingenuity Variant Analysis

What were the top drivers for selecting Ingenuity Variant Analysis?

Access to rich biological content in Ingenuity Knowledge Base plus additional sources of variant level content
70%
Reduced time to identify variants worth following up on
69%
Identify high impact, most compelling variants to follow up on
56%
User friendly interface and no bioinformatics experience needed
51%
Easy to collaborate and share with colleagues and peers
35%
Secure web application that is HIPAA and Safe Harbor compliant
21%
Scalable from small to large studies
20%
Increased trust in the insights received from my experiment
13%

Case Study: Educational Institution and Ingenuity Variant Analysis

Introduction

This case study of a educational institution is based on a March 2013 survey of Ingenuity Systems customers by TechValidate, a 3rd-party research service. The profiled organization asked to have their name blinded to protect their confidentiality.

“Ingenuity Variant Analysis has massively reduced the time it takes to filter variants for prioritization. I can do any type of filtering I like while using the same computational protocol in an intuitive, user friendly interface.”

Challenges

  • Solved the following challenges by deploying Ingenuity Variant Analysis:
    • Realized faster and easier identification of causal variants
    • Reduced IT infrastructure costs
    • Improved access to biological content including primary sources
    • Improved sharing and collaboration capabilities
    • Reduced the need for developing own informatics pipeline
    • Eliminated the need for creating and maintaining own up-to-date database of biomedical literature
    • Enabled independent study without the need for specialized bioinformatics skills
    • Enabled support for more studies by providing a self-service tool for colleagues and collaborators
  • Purchased Ingenuity Variant Analysis for the following reasons:
    • Access rich biological content in Ingenuity Knowledge Base plus additional sources of variant level content
    • Reduce time to identify variants worth following up on
    • Identify high impact, most compelling variants to follow up on
    • Access user friendly interface and no bioinformatics experience needed
    • Secure web application that is HIPAA and Safe Harbor compliant
    • Scale from small to large studies
    • Collaborate and share easily with colleagues and peers

Use Case

  • Uses the following applications with Ingenuity Variant Analysis:
    • DNA sequencing – Whole Genome
    • DNA sequencing – Whole Exome
  • Sequencing data is from the following platforms:
    • Illumina Genome Analyzer (GA) / HiSeq
    • Complete Genomics

Results

  • Chose Ingenuity Systems over the following solutions:
    • In-house developed software
  • Saves > 3 days per sample using Ingenuity Variant Analysis for DNA variant annotation and analysis.
  • Reduced time to results by > 75% by using Ingenuity Variant Analysis for DNA variant annotation and analysis.
  • Rated the following Ingenuity Variant Analysis capabilities in terms of how differentiated they are compared to other data analysis solutions:
    • Speed: 5 (strongly differentiated)
    • Accurate evidence: 3 (differentiated)
    • Accessibility/ ease of use: 5 (strongly differentiated)
    • Sharing with colleagues/peers: 5 (strongly differentiated)
  • Is extremely satisfied with the ease of use of Ingenuity Variant Analysis.

Top Drivers for Selecting IPA for RNA-seq Analysis over In-House Developed Software

What were the top drivers for selecting IPA for RNA seq analysis?

Quickly identify differentially expressed isoforms
33%
Interpret the impact of expression changes in the context of biological processes, disease and cellular phenotypes, and molecular interactions
71%
Visualize your RNA seq data in the context of Isoform View
21%
Compile targeted bibliographies with experimental evidence linking your differentially expressed isoforms to biological processes, disease, and molecular interactions
33%
Other
4%

Case Study: Harvard University and Ingenuity Variant Analysis

Introduction

This case study of Harvard University is based on a March 2013 survey of Ingenuity Systems customers by TechValidate, a 3rd-party research service.

“[Ingenuity Variant Analysis] helped provide clarity, confirmation and graphic visualization of our analysis results.”

Challenges

  • Solved the following challenges by deploying Ingenuity Variant Analysis:
    • Realized faster and easier identification of causal variants
    • Reduced IT infrastructure costs
    • Improved access to biological content including primary sources
    • Improved sharing and collaboration capabilities
    • Reduced the need for developing own informatics pipeline
    • Eliminated the need for creating and maintaining own up-to-date database of biomedical literature
    • Enabled independent study without the need for specialized bioinformatics skills
    • Enabled support for more studies by providing a self-service tool for colleagues and collaborators
  • Purchased Ingenuity Variant Analysis for the following reasons:
    • Access rich biological content in Ingenuity Knowledge Base plus additional sources of variant level content
    • Reduce time to identify variants worth following up on
    • Identify high impact, most compelling variants to follow up on
    • Access user friendly interface and no bioinformatics experience needed
    • Collaborate and share easily with colleagues and peers

Use Case

  • Uses the following applications with Ingenuity Variant Analysis:
    • Gene Pathway Analysis
  • Sequencing data is from the following platforms:
    • Illumina MiSeq

Results

  • Reduced time to results by > 75% by using Ingenuity Variant Analysis for DNA variant annotation and analysis.
  • Rated the following Ingenuity Variant Analysis capabilities in terms of how differentiated they are compared to other data analysis solutions:
    • Accessibility/ ease of use: 3 (differentiated)
    • Speed: 4 (very differentiated)
  • Is satisfied with the ease of use of Ingenuity Variant Analysis.


More to Explore



About QIAGEN Digital Insights

QIAGEN offers industry-leading applications for the analysis, interpretation, and reporting of biological data. Understanding raw data is one of the most significant challenges in modern molecular methods. Data must be examined within the context of complex biological processes, and rapidly increasing throughput makes analyses time and labor intensive. QIAGEN’s portfolio of powerful tools addresses this bottleneck with innovative applications based on cutting-edge bioinformatics.

QIAGEN Digital Insights Website   QIAGEN Website